<DOC>
	<DOCNO>NCT00002310</DOCNO>
	<brief_summary>To evaluate safety tolerance topically apply SP-303T AIDS patient . To observe effect drug herpes simplex virus lesion patient fail heal response oral intravenous acyclovir therapy . The lack alternative treatment herpes simplex virus infection patient AIDS development resistance acyclovir patient require repeat treatment present therapeutic dilemma physician . SP-303T good vitro activity resistant strain offer convenient inexpensive mean drug administration comparison use intravenous medication .</brief_summary>
	<brief_title>SP-303T Applied Skin Patients With Herpes Simplex Virus ( HSV ) Infection AIDS Who Have Not Had Success With Acyclovir</brief_title>
	<detailed_description>The lack alternative treatment herpes simplex virus infection patient AIDS development resistance acyclovir patient require repeat treatment present therapeutic dilemma physician . SP-303T good vitro activity resistant strain offer convenient inexpensive mean drug administration comparison use intravenous medication . Patients receive 14 day ( 42 day ) treatment topically apply SP-303T . SP-303T apply directly onto herpes simplex virus lesion three time daily quantity sufficient thinly cover entire lesion , may cover appropriate dressing , need . At end treatment period , patient enter follow-up period 2 week .</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Immunologic Deficiency Syndromes</mesh_term>
	<mesh_term>Acquired Immunodeficiency Syndrome</mesh_term>
	<mesh_term>Herpes Simplex</mesh_term>
	<mesh_term>Acyclovir</mesh_term>
	<criteria>Inclusion Criteria Patients must : HIV1 infection . AIDS . Chronic mucocutaneous herpes simplex virus ( HSV ) infection , one lesion unresponsive oral acyclovir therapy . No uncontrolled infection HSV . Sufficient mental status understand purpose study comply study requirement . Sufficient general health outpatient come clinic require followup visit . Exclusion Criteria Coexisting Condition : Patients follow symptoms condition exclude : Known hypersensitivity allergy citrus fruit , black currant berry , rise hip . Any disease condition , opinion investigator , would interfere evaluation study drug , affect patient compliance , place patient increase risk . Concurrent Medication : Excluded : Other unapproved investigational new drug . Concurrent therapy herpes simplex virus ( HSV ) infection medication know activity HSV . Required : A minimum 10 day prior oral acyclovir ( least 1 g daily ) 10 day prior intravenous acyclovir ( 15 mg/kg daily ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 1993</verification_date>
	<keyword>Herpes Simplex</keyword>
	<keyword>HIV-1</keyword>
	<keyword>Acquired Immunodeficiency Syndrome</keyword>
	<keyword>Antiviral Agents</keyword>
	<keyword>Administration , Topical</keyword>
</DOC>